Priority Meds vs RNK Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Priority Meds
Best for pending product verificationStarting at $113/mo
RNK Health
Best for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationshipStarting at $197/mo
Side-by-Side Comparison
| Feature | Priority Meds | RNK Health |
|---|---|---|
| Overall Score | 7.1/10 | ✓7.3/10 |
| Starting Price | ✓$113/mo | $197/mo |
| Editorial Rating | 3.6 ★ /5 | ✓3.7 ★ /5 |
| Features | 4 features | ✓5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Priority Meds
Pros
- ✓Flat-dose pricing (no dose-escalation increases) per competitor sources
- ✓B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
- ✓Clearwater FL based US operation
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
RNK Health
Pros
- ✓Both injectable and oral compounded semaglutide formats — wider format optionality than most stub entries in the cluster
- ✓GLP-1 + longevity stack (NAD+, sermorelin, enclomiphene, DNA testing) lets one provider serve readers also interested in performance/longevity adjacencies
- ✓Pricing is publicly displayed — $297/mo tirzepatide, $197/mo injectable semaglutide, $198/mo oral semaglutide
Cons
- ✗States served not enumerated on the public landing page — needs direct confirmation before any state-page placement
- ✗Pharmacy partner not publicly named beyond a Springville, UT fulfillment reference
- ✗Compounded only on the GLP-1 side — no FDA-approved Wegovy/Zepbound brand-name option
Our Verdict
RNK Health edges out Priority Meds with a higher overall score of 7.3/10 and is particularly strong for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship. Priority Meds remains a solid alternative, especially if you're looking for pending product verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.